Target intelligence / Profile preview

Long intergenic non-protein coding RNA 2850 (LINC02850)

Target
LINC02850
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 2850 (LINC02850) is a member of the long non-coding RNA class, which are RNAs over 200 nucleotides in length that do not encode proteins and are transcribed from genomic regions that do not overlap with protein-coding genes[5][7]. LINC02850 has been annotated in human genome databases (e.g., NCBI Gene, Ensembl, HGNC) and is identified primarily by its sequence and locus, with limited functional characterization to date[1][5][7]. There is currently no direct evidence that LINC02850 acts as a disease causal factor, biomarker, or therapeutic target, though the broader lincRNA family is recognized for roles in gene expression regulation and cancer biology[9][10]. As of now, LINC02850 is best described as a genomically annotated long intergenic non-coding RNA with no established role as a therapeutic target or in drug interaction networks.

Other names
LINC02850long intergenic non-protein coding RNA 2850
02

Mechanism of action

None established for drugs, as LINC02850 is not a confirmed therapeutic target

03

Biological functions

Likely involved in gene expression regulation, as typical of lincRNAsSpecific functions for LINC02850 are not described in available curated resources
04

Disease associations

Long intergenic non-coding RNAs (lincRNAs) as a class have established roles in cancer progression, diagnosis, and prognosisNo direct, validated disease role for LINC02850 itself in curated databases or literature as of nowImplicated in genome-wide association studies (GWAS) (e.g., mapped with APOB), but disease relevance remains unclear

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 2850 (LINC02850).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 2850 (LINC02850).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call